Medication adherence in youths with CKD: habits for success
- PMID: 37306720
- PMCID: PMC11587169
- DOI: 10.1007/s00467-023-05976-0
Medication adherence in youths with CKD: habits for success
Abstract
Background: Poor adherence habits are key contributors to nonadherence but there are few clinically feasible methods for evaluating adherence habits, particularly for youths with chronic kidney disease (CKD). This study investigated how participants' qualitative responses to three interview questions about adherence habits mapped to primary principles of habit formation and objectively measured medication adherence in youths with CKD.
Methods: Participants (ages 11-21 years) were recruited from a pediatric nephrology clinic as part of a larger study. Participants' daily objective antihypertensive medication adherence was measured with an electronic pill bottle over a 4-week baseline period. Qualitative interviews about adherence habits and routines were conducted with a subset of participants (N = 18).
Results: Clear qualitative differences emerged in how participants with high-medium adherence (80-100%) discussed adherence habits compared to participants with low adherence (0-79%). Participants with high-medium adherence discussed situational cues for taking medicine, including locations that cue adherence, step-by-step events leading up to taking medicine, and people who cue adherence. Participants with high-medium adherence regularly described taking medicine as "automatic," "second nature," and a "habit." Participants with low adherence rarely discussed these habit features nor did they explicitly acknowledge currently missing doses. Participants with low adherence tended to discuss challenges with organization and routines for taking medicine.
Conclusions: Evaluating patient responses to questions about adherence habits may uncover challenges with adherence habit formation, provide direction for habit-strengthening intervention focused on developing automatic cues for taking medication, and support adherence successes for youths with CKD.
Clinical trial registration number: NCT03651596. A higher resolution version of the Graphical abstract is available as Supplementary information.
Keywords: Chronic kidney disease; Habit; Medication nonadherence.
© 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
Conflict of interest statement
Similar articles
-
Shared decision-making for people with asthma.Cochrane Database Syst Rev. 2017 Oct 3;10(10):CD012330. doi: 10.1002/14651858.CD012330.pub2. Cochrane Database Syst Rev. 2017. PMID: 28972652 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Eliciting adverse effects data from participants in clinical trials.Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2. Cochrane Database Syst Rev. 2018. PMID: 29372930 Free PMC article.
-
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3. Cochrane Database Syst Rev. 2014. PMID: 24777444 Free PMC article.
-
Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2024 Mar 27;3(3):CD011851. doi: 10.1002/14651858.CD011851.pub3. Cochrane Database Syst Rev. 2024. PMID: 38533994 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical